Atlas Trials

Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma

Clinical trial NCT05221398 · COMPLETED

Trial details

NCT number
NCT05221398
Sponsor
Guangxi Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2019-03-03
Primary completion
2023-01-18
Enrollment
517

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.